{
    "vaccineType" : {
      "1119305005" : "antigen",
      "1119349007" : "mRna",
      "J07BX03" : "other"
    },
    "medicalProduct" : {
      "EU/1/20/1528" : "Comirnaty",
      "EU/1/20/1507" : "COVID-19 Vaccine Moderna",
      "EU/1/21/1529" : "Vaxzevria",
      "EU/1/20/1525" : "COVID-19 Vaccine Janssen",
      "CVnCoV" : "CVnCoV",
      "NVX-CoV2373" : "NVX-CoV2373",
      "Sputnik-V" : "Sputnik V",
      "Convidecia" : "Convidecia",
      "EpiVacCorona" : "EpiVacCorona",
      "BBIBP-CorV" : "BBIBP-CorV",
      "Inactivated-SARS-CoV-2-Vero-Cell" : "Inactivated SARS-CoV-2 (Vero Cell)",
      "CoronaVac" : "CoronaVac",
      "Covaxin" : "Covaxin (also known as BBV152 A, B, C)"
    },
    "manufacturer" : {
      "ORG-100001699" : "AstraZeneca AB",
      "ORG-100030215" : "Biontech Manufacturing GmbH",
      "ORG-100001417" : "Janssen-Cilag International",
      "ORG-100031184" : "Moderna Biotech Spain S.L.",
      "ORG-100006270" : "Curevac AG",
      "ORG-100013793" : "CanSino Biologics",
      "ORG-100020693" : "China Sinopharm International Corp. - Beijing location",
      "ORG-100010771" : "Sinopharm Weiqida Europe Pharmaceutical s.r.o. - Prague location",
      "ORG-100024420" : "Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd. - Shenzhen location",
      "ORG-100032020" : "Novavax CZ AS",
      "Gamaleya-Research-Institute" : "Gamaleya Research Institute",
      "Vector-Institute" : "Vector Institute",
      "Sinovac-Biotech" : "Sinovac Biotech",
      "Bharat-Biotech" : "Bharat Biotech"
    }
  }